E
Sangamo Therapeutics, Inc. SGMO
$0.5863 $0.01312.29% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -19.99M -30.60M -23.40M 10.67M -36.13M
Total Depreciation and Amortization 1.90M 1.92M 2.14M 2.13M 2.57M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.26M 2.60M 2.57M 3.43M 6.66M
Change in Net Operating Assets -2.33M -77.00K 15.34M -4.47M 14.00K
Cash from Operations -18.16M -26.15M -3.35M 11.76M -26.88M
Capital Expenditure -24.00K -- -152.00K -115.00K --
Sale of Property, Plant, and Equipment -- -- 1.48M 348.00K 127.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- 0.00 0.00 0.00
Cash from Investing -24.00K -- 1.32M 233.00K 127.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 29.03M 10.36M 7.21M 0.00 --
Repurchase of Common Stock -420.00K -2.23M -220.00K -203.00K -533.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 28.61M 8.13M 6.99M -203.00K -533.00K
Foreign Exchange rate Adjustments 2.73M 1.28M -2.25M 1.13M -257.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 13.16M -16.74M 2.72M 12.92M -27.55M